Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2011
06/16/2011WO2011017596A3 Compositions and methods for identifying and detecting sites of translocation and dna fusion junctions
06/16/2011WO2011014674A3 Microfluidic device for pharmacokinetic-pharmacodynamic study of drugs and uses thereof
06/16/2011WO2011006161A3 Compositions and methods for diagnosing and treating macular degeneration
06/16/2011WO2010117860A3 Microrna signature to predict prognosis in heart failure
06/16/2011WO2010117465A3 Uses for long polar fimbriae genes of pathogenic escherichia coli strains
06/16/2011WO2010056406A8 Use of erbb4 as a prognostic and therapeutic marker for melanoma
06/16/2011US20110145944 Brassica plant comprising mutant fatty acyl-acp thioesterase alleles
06/16/2011US20110145938 Method for generating monoclonal antibodies that recognize progenitor cells
06/16/2011US20110145176 Gene expression profiles to predict breast cancer outcomes
06/16/2011US20110144469 Bacterial/Cellular Recognition Impedance Algorithm
06/16/2011US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products
06/16/2011US20110144206 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
06/16/2011US20110144205 Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure
06/16/2011US20110144076 Preterm delivery diagnostic assay
06/16/2011US20110144065 Selective high-affinity polydentate ligands and methods of making such
06/16/2011US20110144047 Combined method for predicting the response to an anti-cancer therapy
06/16/2011US20110144043 Stat modulators
06/16/2011US20110144029 Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases
06/16/2011US20110144023 Nano Cancer Barrier Device (NCBD) to Immobilize and Inhibit the Division of Metastic Cancer Stem Cells
06/16/2011US20110144009 Brown Adipocyte Progenitors in Human Skeletal Muscle
06/16/2011US20110143998 Identification and use of peptide inhibitors of protein synthesis
06/16/2011US20110143964 Fluidic devices and methods for multiplex chemical and biochemical reactions
06/16/2011US20110143962 Method of evaluating oral cancer risk in human
06/16/2011US20110143960 3d-models for high-throughput screening drug discovery and development
06/16/2011US20110143959 Compositions and methods for determining the prognosis of bladder urothelial cancer
06/16/2011US20110143956 Diagnostic Kits and Methods for SCD or SCA Therapy Selection
06/16/2011US20110143954 Gamma-secretase substrate and methods of use
06/16/2011US20110143950 Diagnosis/Treatment Option for Head-and-Neck Tumor Using Micro-RNA as Biomarker
06/16/2011US20110143949 Analysis using microfluidic partitioning devices
06/16/2011US20110143948 Molecular signatures and biomarkers associated with melanoma and methods of use thereof
06/16/2011US20110143946 Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent
06/16/2011US20110143440 Mutations caused by activation-induced cytidine deaminase
06/16/2011US20110143391 Method for typing and identification of micro-organisms
06/16/2011US20110143390 Method for testing drug sensitivity and device used therefor
06/16/2011US20110143389 Cell analysis apparatus and methods
06/16/2011US20110143388 Method of providing portable biological testing capabilities
06/16/2011US20110143387 Highly water-soluble, cationic luminescent labels
06/16/2011US20110143386 Method for the analysis of o-linked oliosacharides
06/16/2011US20110143385 Plasma membrane vesicles and methods of making and using same
06/16/2011US20110143384 Methods of peptide modification
06/16/2011US20110143383 Microfluidic device
06/16/2011US20110143379 Detection and quantitation of full-length thioredoxin (trx) and truncated thioredoxin (trx 80) in complex samples
06/16/2011US20110143371 Procollagen c-proteinase enhancer (pcpe) biomarker for bone formation
06/16/2011US20110143366 Protein biomarkers for in vitro testing of developmental toxicity and enbryotoxicity of chemical substances
06/16/2011US20110143362 Method for identification of protease activity inhibitors and assaying the presence of protease activity
06/16/2011US20110143361 Predictive value of nuclear excision repair genes for cancer survival
06/16/2011US20110143360 Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent
06/16/2011US20110143359 Method for Identifying Drug-Sensitizing Antisense DNA Fragments and Use Thereof
06/16/2011US20110143358 Compositions for use in identification of tick-borne pathogens
06/16/2011US20110143357 System and method for high resolution analysis of nucleic acids to detect sequence variations
06/16/2011US20110143356 Thermostable polymerases having altered fidelity and methods of identifying and using same
06/16/2011US20110143355 Systems for genome selection
06/16/2011US20110143354 Universal primers and their use for detecting and identifying plant materials in complex mixtures
06/16/2011US20110143353 Method for in vitro detection and/or quantification and/or identification of infectious compounds in a biological material
06/16/2011US20110143352 Methods for the Reduction of Stutter in Microsatellite Amplification
06/16/2011US20110143350 Primers and methods for the detection and discrimination of nucleic acids
06/16/2011US20110143349 Methods and compositions for detecting bk virus
06/16/2011US20110143348 Method for quantifying or detecting dna
06/16/2011US20110143347 Substances and methods for a dna based profiling assay
06/16/2011US20110143346 Cotton event mon15985 and compositions and methods for detection thereof
06/16/2011US20110143345 Genetic Markers for SCD or SCA Therapy Selection
06/16/2011US20110143344 Genetic polymorphisms and substance dependence
06/16/2011US20110143343 Methods and Kits for Methylation Detection
06/16/2011US20110143342 New fetal methylation markers
06/16/2011US20110143341 Microsatellite Markers of Schizophrenia
06/16/2011US20110143340 Non-invasive isolation of fetal nucleic acid
06/16/2011US20110143339 Device, System and Method for Processing a Sample
06/16/2011US20110143338 Nucleic acid enzymes and complexes and methods for their use
06/16/2011US20110143337 Unsymmetrical cyanine dimer compounds and their application
06/16/2011US20110143336 Marker for estimating the diagnosis of cervical adenocarcinoma or for estimating the prognosis of cervical cancer
06/16/2011US20110143335 Methods and sytems to capture competitive molecules
06/16/2011US20110143334 Microbiological systems and methods of fluid sample analysis
06/16/2011US20110143333 Anti-chikungunya monoclonal antibodies and uses thereof
06/16/2011US20110143332 Method for identifying microorganism or detecting its morphology alteration using surface enhanced raman scattering (sers)
06/16/2011US20110142961 Methods and reagents for predicting clinical outcome and customizing chemotherapy in lung cancer patients
06/16/2011US20110142913 Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug
06/16/2011US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection
06/16/2011US20110142862 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
06/16/2011US20110142854 Compositions and methods for inhibition of retroviruses
06/16/2011US20110142838 Novel antibodies against cancer target block tumor growth, angiogenesis and metastatis
06/16/2011US20110142833 Methods for treating and preventing fibrosis
06/16/2011US20110142828 Treatment prediction involving hmgcr
06/16/2011US20110142821 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis
06/16/2011US20110142816 Thermostabilization of proteins
06/16/2011US20110142799 Modulation of neurodegenerative disease by modulating xbp-1 activity
06/16/2011US20110142789 Compositions and Methods for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
06/16/2011US20110142787 Polymerized cyclic nitroxide radical compound and use thereof
06/16/2011US20110142759 Agents and methods for the imaging of myelin basic protein
06/16/2011DE102010027827B3 Verfahren und Mittel zur Identifizierung von Substanzen, welche die IgE-Produktion hemmen Method and means for identifying substances that inhibit the IgE production
06/16/2011DE102010008827B3 Verfahren zur Diagnose oder Prädiagnose von Multipler Sklerose anhand von Einzelnukleotid-Polymorphismen des humanen Chromosoms 4 im Inositol-polyphosphat-4-phosphatase-Typ II-Gen (INPP4b-Gen) Method for the diagnosis or pre-diagnosis of multiple sclerosis based on single nucleotide polymorphisms of human chromosome 4 in inositol polyphosphate 4-phosphatase type II gene (INPP4b gene)
06/16/2011CA2820315A1 Hyperprimers
06/16/2011CA2807050A1 Diagnostic biomarker to identify women at risk for preterm delivery
06/16/2011CA2789053A1 Egfr and pten gene alterations predicts survival in patients with brain tumors
06/16/2011CA2783826A1 Sensor arrangement with snap-off segments
06/16/2011CA2783788A1 Dimeric core-shell nanostructure labeled with raman active molecule localized at interparticle junction, use thereof, and method for preparing the same
06/16/2011CA2783743A1 Phosphatidylinositol-3-kinase pathway biomarkers
06/16/2011CA2783739A1 Categorization of dna samples
06/16/2011CA2783536A1 Biomarker assay for diagnosis and classification of cardiovascular disease
06/16/2011CA2783496A1 Use of the combinatorial diversity of t-lymphocyte repertoire as a prognostic marker of cancer
06/16/2011CA2783242A1 Method for identification of protease activity inhibitors and assaying the presence of protease activity
1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 3003